カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のリツキサン（リツキシマブ）モノクローナル抗体市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Rituxan (Rituximab) Monoclonal Antibody Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM8033）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM8033
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：76
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のリツキサン（リツキシマブ）モノクローナル抗体市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のリツキサン（リツキシマブ）モノクローナル抗体の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のリツキサン（リツキシマブ）モノクローナル抗体市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- リツキサン（リツキシマブ）モノクローナル抗体の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

リツキサン（リツキシマブ）モノクローナル抗体市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・ブランド、バイオシミラー

用途別セグメント
・子供、大人

主要な市場プレーヤー
・Roche、Teva、Pfizer、Amgen

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、リツキサン（リツキシマブ）モノクローナル抗体製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なリツキサン（リツキシマブ）モノクローナル抗体メーカーの企業概要、2019年～2022年までのリツキサン（リツキシマブ）モノクローナル抗体の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なリツキサン（リツキシマブ）モノクローナル抗体メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別リツキサン（リツキシマブ）モノクローナル抗体の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのリツキサン（リツキシマブ）モノクローナル抗体のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのリツキサン（リツキシマブ）モノクローナル抗体市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびリツキサン（リツキシマブ）モノクローナル抗体の産業チェーンを掲載しています。
・第14、15章では、リツキサン（リツキシマブ）モノクローナル抗体の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– リツキサン（リツキシマブ）モノクローナル抗体の概要
– タイプ別分析（2018年vs2022年vs2029年）：ブランド、バイオシミラー
– 用途別分析（2018年vs2022年vs2029年）：子供、大人
– 世界のリツキサン（リツキシマブ）モノクローナル抗体市場規模・予測
– 世界のリツキサン（リツキシマブ）モノクローナル抗体生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Roche、Teva、Pfizer、Amgen
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：ブランド、バイオシミラー
・用途別分析2018年-2029年：子供、大人
・リツキサン（リツキシマブ）モノクローナル抗体の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・リツキサン（リツキシマブ）モノクローナル抗体のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・リツキサン（リツキシマブ）モノクローナル抗体のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・リツキサン（リツキシマブ）モノクローナル抗体の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・リツキサン（リツキシマブ）モノクローナル抗体の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Rituxan (Rituximab) Monoclonal Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Brand
1.3.3 Biosimilar
1.4 Market Analysis by Application
1.4.1 Overview: Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Child
1.4.3 Adult
1.5 Global Rituxan (Rituximab) Monoclonal Antibody Market Size & Forecast
1.5.1 Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity (2018-2029)
1.5.3 Global Rituxan (Rituximab) Monoclonal Antibody Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Rituxan (Rituximab) Monoclonal Antibody Product and Services
2.1.4 Roche Rituxan (Rituximab) Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Rituxan (Rituximab) Monoclonal Antibody Product and Services
2.2.4 Teva Rituxan (Rituximab) Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Rituxan (Rituximab) Monoclonal Antibody Product and Services
2.3.4 Pfizer Rituxan (Rituximab) Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments/Updates
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen Rituxan (Rituximab) Monoclonal Antibody Product and Services
2.4.4 Amgen Rituxan (Rituximab) Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Amgen Recent Developments/Updates
3 Competitive Environment: Rituxan (Rituximab) Monoclonal Antibody by Manufacturer
3.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Manufacturer (2018-2023)
3.2 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Manufacturer (2018-2023)
3.3 Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Rituxan (Rituximab) Monoclonal Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Rituxan (Rituximab) Monoclonal Antibody Manufacturer Market Share in 2022
3.4.2 Top 6 Rituxan (Rituximab) Monoclonal Antibody Manufacturer Market Share in 2022
3.5 Rituxan (Rituximab) Monoclonal Antibody Market: Overall Company Footprint Analysis
3.5.1 Rituxan (Rituximab) Monoclonal Antibody Market: Region Footprint
3.5.2 Rituxan (Rituximab) Monoclonal Antibody Market: Company Product Type Footprint
3.5.3 Rituxan (Rituximab) Monoclonal Antibody Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Rituxan (Rituximab) Monoclonal Antibody Market Size by Region
4.1.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Region (2018-2029)
4.1.2 Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Region (2018-2029)
4.1.3 Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Region (2018-2029)
4.2 North America Rituxan (Rituximab) Monoclonal Antibody Consumption Value (2018-2029)
4.3 Europe Rituxan (Rituximab) Monoclonal Antibody Consumption Value (2018-2029)
4.4 Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Consumption Value (2018-2029)
4.5 South America Rituxan (Rituximab) Monoclonal Antibody Consumption Value (2018-2029)
4.6 Middle East and Africa Rituxan (Rituximab) Monoclonal Antibody Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2018-2029)
5.2 Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Type (2018-2029)
5.3 Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2018-2029)
6.2 Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Application (2018-2029)
6.3 Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Application (2018-2029)
7 North America
7.1 North America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2018-2029)
7.2 North America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2018-2029)
7.3 North America Rituxan (Rituximab) Monoclonal Antibody Market Size by Country
7.3.1 North America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Country (2018-2029)
7.3.2 North America Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2018-2029)
8.2 Europe Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2018-2029)
8.3 Europe Rituxan (Rituximab) Monoclonal Antibody Market Size by Country
8.3.1 Europe Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Country (2018-2029)
8.3.2 Europe Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Market Size by Region
9.3.1 Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2018-2029)
10.2 South America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2018-2029)
10.3 South America Rituxan (Rituximab) Monoclonal Antibody Market Size by Country
10.3.1 South America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Country (2018-2029)
10.3.2 South America Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Market Size by Country
11.3.1 Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Rituxan (Rituximab) Monoclonal Antibody Market Drivers
12.2 Rituxan (Rituximab) Monoclonal Antibody Market Restraints
12.3 Rituxan (Rituximab) Monoclonal Antibody Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Rituxan (Rituximab) Monoclonal Antibody and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rituxan (Rituximab) Monoclonal Antibody
13.3 Rituxan (Rituximab) Monoclonal Antibody Production Process
13.4 Rituxan (Rituximab) Monoclonal Antibody Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rituxan (Rituximab) Monoclonal Antibody Typical Distributors
14.3 Rituxan (Rituximab) Monoclonal Antibody Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Rituxan (Rituximab) Monoclonal Antibody Product and Services
Table 6. Roche Rituxan (Rituximab) Monoclonal Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. Teva Basic Information, Manufacturing Base and Competitors
Table 9. Teva Major Business
Table 10. Teva Rituxan (Rituximab) Monoclonal Antibody Product and Services
Table 11. Teva Rituxan (Rituximab) Monoclonal Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Teva Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Rituxan (Rituximab) Monoclonal Antibody Product and Services
Table 16. Pfizer Rituxan (Rituximab) Monoclonal Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer Recent Developments/Updates
Table 18. Amgen Basic Information, Manufacturing Base and Competitors
Table 19. Amgen Major Business
Table 20. Amgen Rituxan (Rituximab) Monoclonal Antibody Product and Services
Table 21. Amgen Rituxan (Rituximab) Monoclonal Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Amgen Recent Developments/Updates
Table 23. Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 24. Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Manufacturer (2018-2023) & (USD Million)
Table 25. Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 26. Market Position of Manufacturers in Rituxan (Rituximab) Monoclonal Antibody, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 27. Head Office and Rituxan (Rituximab) Monoclonal Antibody Production Site of Key Manufacturer
Table 28. Rituxan (Rituximab) Monoclonal Antibody Market: Company Product Type Footprint
Table 29. Rituxan (Rituximab) Monoclonal Antibody Market: Company Product Application Footprint
Table 30. Rituxan (Rituximab) Monoclonal Antibody New Market Entrants and Barriers to Market Entry
Table 31. Rituxan (Rituximab) Monoclonal Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Region (2018-2023) & (K Units)
Table 33. Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Region (2024-2029) & (K Units)
Table 34. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 35. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 36. Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Region (2018-2023) & (US$/Unit)
Table 37. Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Region (2024-2029) & (US$/Unit)
Table 38. Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 39. Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 40. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Type (2018-2023) & (USD Million)
Table 41. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Type (2024-2029) & (USD Million)
Table 42. Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Type (2018-2023) & (US$/Unit)
Table 43. Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Type (2024-2029) & (US$/Unit)
Table 44. Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 45. Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 46. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Application (2018-2023) & (USD Million)
Table 47. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Application (2024-2029) & (USD Million)
Table 48. Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Application (2018-2023) & (US$/Unit)
Table 49. Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Application (2024-2029) & (US$/Unit)
Table 50. North America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 52. North America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 53. North America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 54. North America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Country (2018-2023) & (K Units)
Table 55. North America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Country (2024-2029) & (K Units)
Table 56. North America Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 57. North America Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 58. Europe Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Europe Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Europe Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 61. Europe Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 62. Europe Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Country (2018-2023) & (K Units)
Table 63. Europe Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Country (2024-2029) & (K Units)
Table 64. Europe Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 68. Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 70. Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Region (2018-2023) & (K Units)
Table 71. Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Region (2024-2029) & (K Units)
Table 72. Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 73. Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 74. South America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 75. South America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 76. South America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 77. South America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 78. South America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Country (2018-2023) & (K Units)
Table 79. South America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Country (2024-2029) & (K Units)
Table 80. South America Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 81. South America Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 82. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 83. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 84. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Region (2018-2023) & (K Units)
Table 87. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales Quantity by Region (2024-2029) & (K Units)
Table 88. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 89. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 90. Rituxan (Rituximab) Monoclonal Antibody Raw Material
Table 91. Key Manufacturers of Rituxan (Rituximab) Monoclonal Antibody Raw Materials
Table 92. Rituxan (Rituximab) Monoclonal Antibody Typical Distributors
Table 93. Rituxan (Rituximab) Monoclonal Antibody Typical Customers
List of Figures
Figure 1. Rituxan (Rituximab) Monoclonal Antibody Picture
Figure 2. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value Market Share by Type in 2022
Figure 4. Brand Examples
Figure 5. Biosimilar Examples
Figure 6. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value Market Share by Application in 2022
Figure 8. Child Examples
Figure 9. Adult Examples
Figure 10. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Rituxan (Rituximab) Monoclonal Antibody Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Rituxan (Rituximab) Monoclonal Antibody by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Rituxan (Rituximab) Monoclonal Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Rituxan (Rituximab) Monoclonal Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Rituxan (Rituximab) Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Rituxan (Rituximab) Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Rituxan (Rituximab) Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Rituxan (Rituximab) Monoclonal Antibody Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Rituxan (Rituximab) Monoclonal Antibody Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Rituxan (Rituximab) Monoclonal Antibody Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Rituxan (Rituximab) Monoclonal Antibody Consumption Value Market Share by Region (2018-2029)
Figure 52. China Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Rituxan (Rituximab) Monoclonal Antibody Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Rituxan (Rituximab) Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Rituxan (Rituximab) Monoclonal Antibody Market Drivers
Figure 73. Rituxan (Rituximab) Monoclonal Antibody Market Restraints
Figure 74. Rituxan (Rituximab) Monoclonal Antibody Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Rituxan (Rituximab) Monoclonal Antibody in 2022
Figure 77. Manufacturing Process Analysis of Rituxan (Rituximab) Monoclonal Antibody
Figure 78. Rituxan (Rituximab) Monoclonal Antibody Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のレミケード（インフリキシマブ）モノクローナル抗体市場2023年：企業・地域・タイプ・用途別分析
  • リツキサン（リツキシマブ）医薬品の世界市場2022：500mg、100mg
  • バイオシミラーモノクローナル抗体の世界市場2022：インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他
  • 世界のベバシズマブモノクローナル抗体バイオシミラー市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM8033 )"世界のリツキサン（リツキシマブ）モノクローナル抗体市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Rituxan (Rituximab) Monoclonal Antibody Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。